NCT02730611View on ClinicalTrials.gov

Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma

CompletedOBSERVATIONAL
Enrollment

124

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

December 31, 2018

Conditions
Morbid ObesityVertical Sleeve GastrectomyMetabolic SyndromeHepatocellular CarcinomaCholangiocarcinomaDisorder of Bile Acid and Cholesterol Metabolism
Trial Locations (1)

92141

AP-HP, Antoine Béclère Hospital, Clamart

All Listed Sponsors
collaborator

National Cancer Institute, France

OTHER_GOV

collaborator

Centre International de la Recherche sur le Cancer

UNKNOWN

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02730611 - Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma | Biotech Hunter | Biotech Hunter